Kolexia
Calderon Benoit
Oncologie radiothérapie
Imag En Coupes Avig Vaucl Site Ste Cat
Avignon, France
56 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinome épidermoïde Carcinomes Tumeurs de la tête et du cou Métastase tumorale Carcinome épidermoïde de la tête et du cou Pseudokystes mucoïdes juxta-articulaires Hémorragie Stomatite aphteuse Pharyngite

Industries

AstraZeneca
8 collaboration(s)
Dernière en 2023
MSD
3 collaboration(s)
Dernière en 2022
Merck-Serono
2 collaboration(s)
Dernière en 2023
Mylan Medical
2 collaboration(s)
Dernière en 2022

Dernières activités

PembroMetaRT: Randomized Trial of Loco-regional Radiotherapy Added to Pembrolizumab Alone or With Chemotherapy Versus Systemic Treatment Alone for Patients With Newly Diagnosed Head and Neck Squamous Cell Carcinoma With Synchronous Metastases
Essai Clinique (Unicancer)   12 octobre 2023
OSCAR: Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   16 août 2023
Stereotactic radiotherapy for brain metastases: predictive factors of radionecrosis.
European journal of medical research   13 juillet 2023
Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial.
European journal of cancer (Oxford, England : 1990)   09 janvier 2023
OPEN: Trismus Prevalence and Preventive Rehabilitation Associated With Therapeutic Education for Patients With Head and Neck Cancer Treated With Concomitant Radiochemotherapy
Essai Clinique (Institut du Cancer de Montpellier)   29 novembre 2022
Prévention Cancers ORL : Fumeuse depuis mes 18 ans, je me suis palpée un ganglion dans le cou...
Youtube @ Merck France   20 septembre 2022
Prévention des cancers ORL : "J'ai un aphte sur la langue qui grossit depuis 1 mois..."
Youtube @ Merck France   20 septembre 2022
695P Effectiveness and quality-of-life (QoL) data from real-world study (ProNiHN) in patients (pts) with recurrent and/or metastatic squamous cell carcinoma of head and neck (R/M SCCHN) treated with nivolumab (nivo) in France
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
LBA33 5-year overall survival (OS) in patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN) treated with xevinapant + chemoradiotherapy (CRT) vs placebo + CRT in a randomized, phase II study
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
653O Neoadjuvant nivolumab (N) before chemoradiation (CRT) in high-risk HPV driven oropharynx cancer (OPC) - IMMUNEBOOST-HPV: A multicenter randomized phase II trial
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022